114 related articles for article (PubMed ID: 25737948)
1. Decreased expression of hepatic glucokinase in type 2 diabetes.
Haeusler RA; Camastra S; Astiarraga B; Nannipieri M; Anselmino M; Ferrannini E
Mol Metab; 2015 Mar; 4(3):222-6. PubMed ID: 25737948
[TBL] [Abstract][Full Text] [Related]
2. Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans.
Peter A; Stefan N; Cegan A; Walenta M; Wagner S; Königsrainer A; Königsrainer I; Machicao F; Schick F; Häring HU; Schleicher E
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1126-30. PubMed ID: 21490074
[TBL] [Abstract][Full Text] [Related]
3. Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1- and G6PC-mediated gluconeogenesis.
Yang H; Su M; Liu M; Sheng Y; Zhu L; Yang L; Mu R; Zou J; Liu X; Liu L
Acta Pharm Sin B; 2023 Sep; 13(9):3728-3743. PubMed ID: 37719384
[TBL] [Abstract][Full Text] [Related]
4. Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes.
Iynedjian PB; Marie S; Gjinovci A; Genin B; Deng SP; Buhler L; Morel P; Mentha G
J Clin Invest; 1995 May; 95(5):1966-73. PubMed ID: 7738162
[TBL] [Abstract][Full Text] [Related]
5. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
6. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
7. [Effects of duodenal-jejunal bypass and sleeve gastrectomy on the expression of liver glucokinase in diabetic rats].
Zhou DL; Zhang DY; Hu XG; Chen DL; Ke ZW; Yin K; Li JH; Zheng CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):558-61. PubMed ID: 19921562
[TBL] [Abstract][Full Text] [Related]
8. Role of Mig-6 in hepatic glucose metabolism.
Yoo JY; Kim TH; Kong S; Lee JH; Choi W; Kim KS; Kim HJ; Jeong JW; Ku BJ
J Diabetes; 2016 Jan; 8(1):86-97. PubMed ID: 25594850
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of a glucokinase point mutant in the treatment of diabetes mellitus.
Lu G; Teng X; Zheng Z; Zhang R; Peng L; Zheng F; Liu J; Huang H; Xiong H
Gene Ther; 2016 Apr; 23(4):323-9. PubMed ID: 26752353
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.
Li YG; Ji DF; Zhong S; Lin TB; Lv ZQ
Chem Biol Interact; 2015 Jan; 225():70-9. PubMed ID: 25446853
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin induced hyperlactatemia and hypoglycemia is linked to decreased mitochondrial phosphoenolpyruvate carboxykinase.
Caton PW; Nayuni NK; Murch O; Corder R
Life Sci; 2009 May; 84(21-22):738-44. PubMed ID: 19268478
[TBL] [Abstract][Full Text] [Related]
12. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats.
Prasath GS; Pillai SI; Subramanian SP
Eur J Pharmacol; 2014 Oct; 740():248-54. PubMed ID: 25064342
[TBL] [Abstract][Full Text] [Related]
13. Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice.
Penhoat A; Fayard L; Stefanutti A; Mithieux G; Rajas F
Metabolism; 2014 Jan; 63(1):104-11. PubMed ID: 24135501
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional changes in glucokinase expression in the brainstem dorsal vagal complex in a murine model of type 1 diabetes.
Halmos KC; Gyarmati P; Xu H; Maimaiti S; Jancsó G; Benedek G; Smith BN
Neuroscience; 2015 Oct; 306():115-22. PubMed ID: 26297899
[TBL] [Abstract][Full Text] [Related]
15. Upregulated hepatic expression of mitochondrial PEPCK triggers initial gluconeogenic reactions in the HCV-3 patients.
Sheikh TI; Adam T; Qadri I
Asian Pac J Trop Med; 2015 Aug; 8(8):618-23. PubMed ID: 26321514
[TBL] [Abstract][Full Text] [Related]
16. High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes.
McCarty MF
Med Hypotheses; 1999 May; 52(5):401-6. PubMed ID: 10416947
[TBL] [Abstract][Full Text] [Related]
17. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.
Torres TP; Catlin RL; Chan R; Fujimoto Y; Sasaki N; Printz RL; Newgard CB; Shiota M
Diabetes; 2009 Jan; 58(1):78-86. PubMed ID: 18952838
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
19. Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats.
Valera A; Rodriguez-Gil JE; Bosch F
J Clin Invest; 1993 Jul; 92(1):4-11. PubMed ID: 8100835
[TBL] [Abstract][Full Text] [Related]
20. Effects of liraglutide on β-cell-specific glucokinase-deficient neonatal mice.
Shirakawa J; Tanami R; Togashi Y; Tajima K; Orime K; Kubota N; Kadowaki T; Goshima Y; Terauchi Y
Endocrinology; 2012 Jul; 153(7):3066-75. PubMed ID: 22569791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
